|
| 37330413 | Circulating tumor DNA as a Predictive and Prognostic Biomarker in the Perioperative Treatment of Muscle-invasive Bladder Cancer: A Systematic Review. | Eur Urol Oncol | 2024 |
| 37802683 | Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma. | Eur Urol | 2024 |
| 37953505 | Incidence, risk factors, and temporal trends of penile cancer: a global population-based study. | BJU Int | 2024 |
| 37904652 | Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer. | BJU Int | 2024 |
| 37707243 | Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023. | J Urol | 2024 |
| 37980250 | Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023? | Eur Urol Oncol | 2024 |
| 37813746 | Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. | Eur Urol Oncol | 2024 |
| 37312504 | Patient and caregiver experience with telepharmacy in cancer care to support beginning systemic therapy: A qualitative study. | J Oncol Pharm Pract | 2024 |
| 37442673 | The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features. | Eur Urol Oncol | 2024 |
| 37208237 | Management of Lymph Node-positive Penile Cancer: A Systematic Review. | Eur Urol | 2024 |
| 36376169 | A Systematic Review of Published Clinical Trials in the Systemic Treatment of Adrenocortical Carcinoma: An Initiative Led on Behalf of the Global Society of Rare Genitourinary Tumors. | Clin Genitourin Cancer | 2023 |
| 37561425 | Immunotherapy in the Treatment of Localized Genitourinary Cancers. | JAMA Oncol | 2023 |
| 38071107 | Systematic Review and Meta-analysis of Minimally Invasive Procedures for Surgical Inguinal Nodal Staging in Penile Carcinoma. | Eur Urol Focus | 2023 |
| 37851909 | The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy. | Can Urol Assoc J | 2023 |
| 37509374 | The Prognostic Role of Human Papillomavirus and p16 Status in Penile Squamous Cell Carcinoma-A Systematic Review. | Cancers (Basel) | 2023 |
| 37509297 | An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery. | Cancers (Basel) | 2023 |
| 37507285 | Surgical templates for inguinal lymph node dissection in cN0 penile cancer: A comparative study. | Urol Oncol | 2023 |
| 37505486 | A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder. | Clin Cancer Res | 2023 |
| 37690543 | Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients. | Urology | 2023 |
| 37880002 | Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer. | Urol Oncol | 2023 |
| 37563779 | Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors. | J Natl Cancer Inst | 2023 |
| 35704436 | First-line programmed death receptor-1 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage IV penile cancer. | BJU Int | 2023 |
| 37457132 | Revisiting mechanisms of resistance to immunotherapies in metastatic clear-cell renal-cell carcinoma. | Cancer Drug Resist | 2023 |
| 37217696 | Author Correction: Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease. | Nat Rev Urol | 2023 |
| 37156477 | Telemedicine Adoption in an NCI-Designated Cancer Center During the COVID-19 Pandemic: A Report on Patient Experience of Care. | J Natl Compr Canc Netw | 2023 |
| 37187719 | Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer. | Eur Urol Open Sci | 2023 |
| 37185232 | Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. | J Immunother Cancer | 2023 |
| 37314813 | Stage-dependent survival in patients treated with neoadjuvant chemotherapy and radical cystectomy. | Minerva Urol Nephrol | 2023 |
| 37149462 | Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6. | Eur Urol | 2023 |
| 37344326 | Racial differences in survival for early stage (T1) penile cancer: Analysis from the SEER database. | Urol Oncol | 2023 |
| 36977797 | Circulating and urinary tumour DNA in urothelial carcinoma - upper tract, lower tract and metastatic disease. | Nat Rev Urol | 2023 |
| 36975458 | Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension. | Curr Oncol | 2023 |
| 37467807 | Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care? | Urology | 2023 |
| 37337409 | Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance. | Cancer | 2023 |
| 37037737 | Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey. | Clin Genitourin Cancer | 2023 |
| 37268448 | Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604-610. | Eur Urol Oncol | 2023 |
| 37196060 | Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry. | Oncologist | 2023 |
| 36626174 | Estimated Indirect Cost Savings of Using Telehealth Among Nonelderly Patients With Cancer. | JAMA Netw Open | 2023 |
| 36883752 | Patient and caregiver experience with telehealth for surgical cancer care: A qualitative study. | J Surg Oncol | 2023 |
| 36624008 | The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit. | Clin Genitourin Cancer | 2023 |
| 36652397 | Concomitant vs Staged Therapeutic Inguinal Lymphadenectomy in Clinically Node Positive Penile Squamous Cell Carcinoma: Does It Make a Difference? | J Urol | 2023 |
| 36719682 | Estimated Carbon Emissions Savings With Shifts From In-Person Visits to Telemedicine for Patients With Cancer. | JAMA Netw Open | 2023 |
| 36917021 | Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy. | Oncologist | 2023 |
| 36512451 | Selection of best videos of the year for 2022. | Int Braz J Urol | 2023 |
| 36509668 | Humanization in oncology care: A necessary change. | Urol Oncol | 2023 |
| 36804719 | An Exercise Prescription To Improve Posture, Minimize Injury, and Improve Career Longevity in Surgeons. | Eur Urol Focus | 2023 |
| 36803025 | Enlisting Urologists to Improve Palliative Care Services Integration in the Care of Advanced Penile Cancer. | J Urol | 2023 |
| 36424078 | The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer. | Urol Clin North Am | 2023 |
| 36906413 | European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update. | Eur Urol | 2023 |
| 36797084 | Cost Effectiveness of Treatment Sequences in Advanced Renal Cell Carcinoma. | Eur Urol Oncol | 2023 |